A detailed history of Groupama Asset Managment transactions in Incyte Corp stock. As of the latest transaction made, Groupama Asset Managment holds 59,597 shares of INCY stock, worth $4.1 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
59,597
Previous 53,492 11.41%
Holding current value
$4.1 Million
Previous $3.24 Billion 2.47%
% of portfolio
0.08%
Previous 0.04%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$57.33 - $68.61 $349,999 - $418,864
6,105 Added 11.41%
59,597 $3.16 Billion
Q2 2024

Aug 14, 2024

BUY
$51.18 - $63.75 $152,209 - $189,592
2,974 Added 5.89%
53,492 $3.24 Billion
Q1 2024

May 14, 2024

SELL
$56.55 - $66.59 $1.02 Million - $1.21 Million
-18,120 Reduced 26.4%
50,518 $3.7 Billion
Q4 2023

Feb 14, 2024

BUY
$52.16 - $64.19 $3.58 Million - $4.41 Million
68,638 New
68,638 $4.31 Billion

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15.3B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Groupama Asset Managment Portfolio

Follow Groupama Asset Managment and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Groupama Asset Managment, based on Form 13F filings with the SEC.

News

Stay updated on Groupama Asset Managment with notifications on news.